COX SRL
2.2 FTEThe score of COX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -2 % Total assets -1 % Headcount (avg FTE) -12 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
COX's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 85,004 € | ||||
| Equity | 742,431 € | ||||
| Cash | 234,890 € | ||||
| EBITDA | 190,689 € | ||||
| Total assets | 917,941 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jul 2026
- Year ended 31 Dec 2024filed on 14 Aug 2025
- Year ended 31 Dec 2023filed on 08 Aug 2024
- Year ended 31 Dec 2022filed on 25 Aug 2023
- Year ended 31 Dec 2021filed on 14 Jun 2022
COX's financial analysis
- Solvency80.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of COX
COX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0426.728.635
- VAT number
- BE0426728635
- Peppol
- Registered · 0208:0426728635 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Dec 1984
- Registered office
- 3511 Hasselt
- Size
- Micro · 2.2 FTE
- Latest accounts
- 2025 · filed on 22 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
COX (SRL) has been based in Hasselt since 1984, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 85,004 € and equity of 742,431 €; its revenue is not published. With 2.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 80.9%, above the median of its sector (44.2%).
Companies similar to COX
Companies in the same business, of comparable size and area, outside its group.
- Apotheek A. Smeets Retail sale of pharmaceutical products Hasselt · balance sheet 927,785 €
- Pharmacie Kerkovre Retail sale of pharmaceutical products Comblain-au-Pont · balance sheet 917,966 €
- Holsbeek Deurne Retail sale of pharmaceutical products Antwerp · balance sheet 917,585 €
- Yokriphar Retail sale of pharmaceutical products Tienen · balance sheet 919,785 €
- Propharma Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet 915,541 €
- Maral Pharma Retail sale of pharmaceutical products Châtelet · balance sheet 920,622 €
- Pharma 9220 Retail sale of pharmaceutical products Hamme (Vl.) · balance sheet 915,194 €
- Pharmatrente Retail sale of pharmaceutical products Charleroi · balance sheet 924,033 €
Frequently asked questions about COX
What is the revenue of COX?
COX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of COX?
In Belgium, the VAT number is the company number prefixed with BE: BE0426728635 for COX, if the company is VAT-registered. Its company number (CBE) is 0426.728.635.
Where is the registered office of COX?
According to the CBE register, the registered office of COX is in 3511 Hasselt.
What is the equity of COX?
At the close of the 2025 financial year, the equity of COX amounts to 742,431 €, a solvency of 80.9% of total assets.
How many people work at COX?
2.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages COX?
The register lists 1 active mandates at COX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of COX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →